Contineum Therapeutics (CTNM) EBIT (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly EBIT of -$17.4 million for Q2 2026, up 2.65% year-over-year from -$17.0 million in Q2 2025, and down 3.1% quarter-over-quarter from -$16.9 million in Q1 2026.
Contineum Therapeutics (CTNM) EBIT (2023 - 2026) Analysis & Trends
Contineum Therapeutics' EBIT history runs 4 years deep, the most recent figure standing at -$17.4 million for Q2 2026.
- In Q2 2026, EBIT rose 2.65% year-over-year to -$17.4 million; the TTM figure through Jun 2026 stood at -$66.4 million (down 0.52% YoY), while the FY2025 annual figure was -$68.1 million, down 33.73% from the prior year.
- EBIT for Q2 2026 stood at -$17.4 million, down from -$16.9 million in the prior quarter.
- The five-year high for EBIT was $38.9 million in Q2 2023, with the low at -$18.1 million in Q1 2025.
- The 4-year median for EBIT is -$14.0 million (2024), against an average of -$9.8 million.
- The sharpest annual moves came in 2024 and 2026: EBIT plunged 128.11% in 2024, then increased 6.66% in 2026.
- Contineum Therapeutics' EBIT stood at -$9.7 million in 2023, then sank by 76.18% to -$17.0 million in 2024, then dropped by 0.4% to -$17.1 million in 2025, then declined by 1.83% to -$17.4 million in 2026.
- Business Quant data shows CTNM's EBIT at -$17.4 million in Q2 2026, -$16.9 million in Q1 2026, and -$17.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | -17.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.43 Mn |
| Mar 31, 2026 | -16.90 Mn |
| Dec 31, 2025 | -17.12 Mn |
| Sep 30, 2025 | -14.93 Mn |
| Jun 30, 2025 | -17.90 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Dec 31, 2024 | -17.05 Mn |
| Sep 30, 2024 | -12.97 Mn |
| Jun 30, 2024 | -10.94 Mn |
| Mar 31, 2024 | -9.93 Mn |
| Dec 31, 2023 | -9.68 Mn |
| Sep 30, 2023 | -8.07 Mn |
| Jun 30, 2023 | 38.94 Mn |
| Mar 31, 2023 | -5.12 Mn |